drugset / Trial / NCT06378879

Intermittent Boluses Versus Infusion of Propofol During Gastroscopy

NCT06378879 ↗

Non-randomizedParallel-groupOpen-labelSupportive care

Summary

It is unclear whether continuous infusion or intermittent bolus injection of propofol is better for achieving adequate sedation during a standard upper endoscopy. The study aimed to compare the efficacy and safety of continuous infusion and intermittent bolus injection of Propofol (Diprivan) during a standard upper endoscopy. In this prospective study, patients will be randomly assigned to undergo a standard upper endoscopy with either continuous infusion (CI group) or intermittent bolus injection (BI group) of Propofol (Diprivan) administered by an anesthesiologist. The primary outcome will be to assess the quality of sedation by the endoscopist (VAS). In addition to other sedation-related parameters that will include sedation induction time (minutes), total dose of propofol (mg), recovery time (minutes) using Aldrete score, any involuntary patient movement, and adverse events.

Timeline

Start
2024-09-06
Primary completion
2025-04-30
Completion
2025-07-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 3 mg/kg —
Comparator Propofol Small molecule 20 mg —

Indications

No indication recorded.